Health Status of Asylum Seekers, Spain

View More View Less
  • 1 Tropical Medicine and International Health Unit Vall d’Hebron-Drassanes, PROSICS, Hospital Universitari Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain;
  • | 2 Department of Basic Clinical Practice, Institut de Investigacions biomédiques August Pi i Sunyer, Barcelona, Spain;
  • | 3 Pediatric Infectious Diseases Unit, PROSICS, Hospital Universitari Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain;
  • | 4 Department of Psychiatric, PROSICS, Hospital Universitari Vall d’Hebron, CIBERSAM, Institut Català de la Salut, Barcelona, Spain and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain;
  • | 5 Department of Microbiology, PROSICS, Hospital Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain;
  • | 6 Department of Infectious Diseases, PROSICS, Hospital Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain

The rising rate of conflicts and the unsafe situation caused by reasons of ethnicity, religion, gender, sexual orientation, political opinion, or nationality entail an increase in the number of migratory movements. The goal of this article is to describe the health status of asylum seekers visited in an international health center. We conducted a retrospective study of the asylum seekers visited between July 2013 and June 2016. A total of 303 cases were included. The median age was 28.0 years (interquartile range [IQR]: 21–35), and 203 (67.0%) were men. Of the total, 128 cases (42.2%) were from Asia, 82 (27.1%) from Eastern Europe, 42 (13.9%) from sub-Saharan Africa, 34 (11.2%) from America, and 17 (5.6%) from Maghreb. The majority, 287 (94.7%), were asymptomatic. Seventy of the 303 (23.1%) cases were diagnosed with at least one infection, this being more prevalent in men; migrants from sub-Saharan Africa; and in those who took a land-maritime migratory route. Eight of the 303 (2.6%) cases were referred to the transcultural psychiatric department. Two important challenges of the study were the communication barriers and the legal or social situation that condition the psychological symptoms. In 48 of the 303 (15.8%) cases, there was diagnosed a noncommunicable diseases. The process of care was completed by 82.5%; although 21.9% completed the vaccination for hepatitis B. The asylum seekers in this study were in general healthy young men, although special attention was given to infectious diseases with certain geoepidemiological backgrounds. Unstable living arrangements, linguistic, and cultural barriers could account for the failure of the course of care.

Author Notes

Address correspondence to Núria Serre-Delcor, Tropical Medicine and International Health Unit Vall d’Hebron-Drassanes, PROSICS, Hospital Vall d’Hebron, Institut Català de la Salut, Avinguda Drassanes, 17-21, 08001 Barcelona, Spain. E-mail: n.serre@vhebron.net

Financial support: All the work has been done without any funding or sponsor support which could constitute a conflict of interest.

Authors’ addresses: Nuria Serre-Delcor, Begoña Treviño-Maruri, Diana Pou-Ciruelo, and Cristina Bocanegra-Garcia, Tropical Medicine and International Health Unit Vall d’Hebron-Drassanes, PROSICS, Hospital Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain, E-mails: n.serre@vhebron.net, mtrevino@vhebron.net, d.pou@vhebron.net, and cristinabocanegra@gmail.com. Carlos Ascaso, Department of Fontanets Clinics, Institut de Investigacions biomédiques August Pi i Sunyer, Barcelona, Spain, E-mail: carlosascaso@ub.edu. Antonio Soriano-Arandes, Pediatric Infectious Diseases Unit, Hospital Vall d’Hebron, Institut Catala de la Salut, Barcelona, Spain, E-mail: asoriano@vhebron.net. Francisco Collazos-Sanchez, Department of Psychiatric, Hospital Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain, E-mail: fcollazo@vhebron.net. Elena Sulleiro, Departement of Microbiology, PROSICS, Hospital Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain, E-mail: esulleir@vhebron.net. Israel Molina-Romero, Department of Infectious diseases, PROSICS, Hospital Vall d’Hebron, Institut Català de la Salut, Barcelona, Spain, E-mail: imolina@vhebron.net.

Save